Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

NCT02852551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PAT-1251
DRUG: Placebo

Sponsor

PharmAkea, Inc.